Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies (Q60045509)

11

Florian Krammer

0 references

Richard Webby

10

Richard Webby

0 references

Rie Nakajima

1

Rie Nakajima

0 references

Philip L. Felgner

13

Philip L Felgner

0 references

D Huw Davies

14

D Huw Davies

0 references

Joshua M Obiero

6

Joshua Obiero

0 references

Aarti Jain

4

Aarti Jain

0 references

Omid Taghavian

5

Omid Taghavian

0 references

Medalyn Supnet

2

Medalyn Supnet

0 references

author name string

Donald K Milton

7

0 references

Wilbur H Chen

8

0 references

Michael Grantham

9

0 references

Darrick Carter

Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses

12

0 references

language of work or name

English

0 references

publication date

12 December 2018

0 references

published in

mSphere

0 references

volume

3

0 references

issue

6

0 references

cites work

1 reference

12 December 2020

Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus.

1 reference

12 December 2020

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

1 reference

12 December 2020

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

1 reference

12 December 2020

Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin

1 reference

12 December 2020

Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs

1 reference

12 December 2020

Mucosal immunity to influenza without IgA: an IgA knockout mouse model

1 reference

12 December 2020

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection

1 reference

12 December 2020

Impairment of mucosal immunity by total parenteral nutrition: requirement for IgA in murine nasotracheal anti-influenza immunity

1 reference

12 December 2020

Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells

1 reference

12 December 2020

A history of influenza

1 reference

12 December 2020

Role of mucosal immunity in influenza.

1 reference

12 December 2020

Mapping the antigenic and genetic evolution of influenza virus

1 reference

12 December 2020

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

1 reference

12 December 2020

THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses

1 reference

12 December 2020

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

1 reference

12 December 2020

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

12 December 2020

Antibody recognition of a highly conserved influenza virus epitope

1 reference

12 December 2020

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

1 reference

12 December 2020

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

1 reference

12 December 2020

Profiling of humoral immune responses to influenza viruses by using protein microarray

1 reference

12 December 2020

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

1 reference

12 December 2020

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design

1 reference

12 December 2020

Toward a universal influenza virus vaccine: prospects and challenges

1 reference

12 December 2020

Broadly neutralizing antiviral antibodies

1 reference

12 December 2020

H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice

1 reference

12 December 2020

Characterization of influenza vaccine immunogenicity using influenza antigen microarrays.

1 reference

12 December 2020

Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses

1 reference

12 December 2020

Universal anti-neuraminidase antibody inhibiting all influenza A subtypes

1 reference

12 December 2020

Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011-2013 in Corsica, France.

1 reference

12 December 2020

Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution

1 reference

12 December 2020

Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study

1 reference

12 December 2020

Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

1 reference

12 December 2020

Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults.

1 reference

12 December 2020

Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization

1 reference

12 December 2020

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

1 reference

12 December 2020

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

1 reference

12 December 2020

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans

1 reference

12 December 2020

Getting more out of less--a quantitative serological screening tool for simultaneous detection of multiple influenza A hemagglutinin-types in chickens

1 reference

12 December 2020

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

1 reference

12 December 2020

Advances in the development of influenza virus vaccines.

1 reference

12 December 2020

Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.

1 reference

12 December 2020

Evaluation of quantum dot immunofluorescence and a digital CMOS imaging system as an alternative to conventional organic fluorescence dyes and laser scanning for quantifying protein microarrays

1 reference

12 December 2020

Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine

1 reference

12 December 2020

Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection

1 reference

12 December 2020

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

1 reference

12 December 2020

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection

1 reference

12 December 2020

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

1 reference

12 December 2020

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

1 reference

12 December 2020

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

1 reference

12 December 2020

Structural Basis of Zika Virus-Specific Antibody Protection

1 reference

12 December 2020

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

1 reference

12 December 2020

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

1 reference

12 December 2020

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

1 reference

12 December 2020

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines

1 reference

12 December 2020

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).

1 reference

12 December 2020

Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards

1 reference

12 December 2020

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

1 reference

12 December 2020

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

1 reference

12 December 2020